Literature DB >> 9751051

Crystal structure of the complex of the cyclin D-dependent kinase Cdk6 bound to the cell-cycle inhibitor p19INK4d.

D H Brotherton1, V Dhanaraj, S Wick, L Brizuela, P J Domaille, E Volyanik, X Xu, E Parisini, B O Smith, S J Archer, M Serrano, S L Brenner, T L Blundell, E D Laue.   

Abstract

The crystal structure of the cyclin D-dependent kinase Cdk6 bound to the p19 INK4d protein has been determined at 1.9 A resolution. The results provide the first structural information for a cyclin D-dependent protein kinase and show how the INK4 family of CDK inhibitors bind. The structure indicates that the conformational changes induced by p19INK4d inhibit both productive binding of ATP and the cyclin-induced rearrangement of the kinase from an inactive to an active conformation. The structure also shows how binding of an INK4 inhibitor would prevent binding of p27Kip1, resulting in its redistribution to other CDKs. Identification of the critical residues involved in the interaction explains how mutations in Cdk4 and p16INK4a result in loss of kinase inhibition and cancer.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9751051     DOI: 10.1038/26164

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  46 in total

Review 1.  CDK-related protein kinases in plants.

Authors:  J Joubès; C Chevalier; D Dudits; E Heberle-Bors; D Inzé; M Umeda; J P Renaudin
Journal:  Plant Mol Biol       Date:  2000-08       Impact factor: 4.076

2.  CAK-independent activation of CDK6 by a viral cyclin.

Authors:  P Kaldis; P M Ojala; L Tong; T P Mäkelä; M J Solomon
Journal:  Mol Biol Cell       Date:  2001-12       Impact factor: 4.138

3.  Crystal structure of human protein kinase CK2: insights into basic properties of the CK2 holoenzyme.

Authors:  K Niefind; B Guerra; I Ermakowa; O G Issinger
Journal:  EMBO J       Date:  2001-10-01       Impact factor: 11.598

Review 4.  Integration of the pRB and p53 cell cycle control pathways.

Authors:  C L Stewart; A M Soria; P A Hamel
Journal:  J Neurooncol       Date:  2001-02       Impact factor: 4.130

5.  Novel mutations in the RFXANK gene: RFX complex containing in-vitro-generated RFXANK mutant binds the promoter without transactivating MHC II.

Authors:  Wojciech Wiszniewski; Marie-Claude Fondaneche; Pascale Louise-Plence; Ada Prochnicka-Chalufour; Françoise Selz; Cappucine Picard; Françoise Le Deist; Jean-François Eliaou; Alain Fischer; Barbara Lisowska-Grospierre
Journal:  Immunogenetics       Date:  2003-01-16       Impact factor: 2.846

6.  Crystal structure of a 12 ANK repeat stack from human ankyrinR.

Authors:  Peter Michaely; Diana R Tomchick; Mischa Machius; Richard G W Anderson
Journal:  EMBO J       Date:  2002-12-02       Impact factor: 11.598

Review 7.  Cell cycle control mechanisms in B-1 and B-2 lymphoid subsets.

Authors:  Michael J Piatelli; Debra Tanguay; Thomas L Rothstein; Thomas C Chiles
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

8.  The ω-3 epoxide of eicosapentaenoic acid inhibits endothelial cell proliferation by p38 MAP kinase activation and cyclin D1/CDK4 down-regulation.

Authors:  Pei H Cui; Nenad Petrovic; Michael Murray
Journal:  Br J Pharmacol       Date:  2011-03       Impact factor: 8.739

9.  INK4d-deficient mice are fertile despite testicular atrophy.

Authors:  F Zindy; J van Deursen; G Grosveld; C J Sherr; M F Roussel
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

Review 10.  Selectivity and potency of cyclin-dependent kinase inhibitors.

Authors:  Jayalakshmi Sridhar; Nagaraju Akula; Nagarajan Pattabiraman
Journal:  AAPS J       Date:  2006-03-24       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.